Bio-Rad Laboratories | BIO - Current Assets


Bio-Rad Laboratories reported $2.91B in Current Assets for its fiscal quarter ending in December of 2025.





Current Assets Change Date
Abbott USD 26B 1.16B Dec/2025
Agilent USD 4.62B 21M Dec/2025
Becton, Dickinson and Co. USD 9.19B 66M Dec/2025
Bio Techne USD 637.43M 27.92M Dec/2025
Bio-Rad Laboratories USD 2.91B 64.2M Dec/2025
Bruker USD 2.21B 138.1M Dec/2025
Charles River Laboratories USD 1.45B 85.06M Dec/2025
Danaher USD 12.76B 3.15B Dec/2025
General Electric Aerospace USD 40.6B 522M Dec/2025
Hologic USD 3.84B 175.3M Dec/2025
Illumina USD 3.29B 493M Dec/2025
IQVIA Holdings USD 6.25B 270M Dec/2025
Laboratory Of America USD 4.02B 58.3M Dec/2025
Merck USD 47.56B 10.49B Sep/2025
Mettler Toledo International USD 1.36B 81.46M Dec/2025
Myriad Genetics USD 332.6M 12.2M Dec/2025
OraSure Technologies USD 261.91M 21.1M Dec/2025
Pacific Biosciences Of California USD 375.05M 19.18M Dec/2025
Quest Diagnostics USD 2.38B 29M Dec/2025
Repligen USD 1.14B 40.9M Dec/2025
Revvity USD 2.24B 95.96M Dec/2025
Roche Holding CHF 38.73B 3.03B Dec/2025
Siemens EUR 67.91B 3.2B Dec/2025
Standard Biotools USD 454.26M 18.18M Dec/2025
Thermo Fisher Scientific USD 28.71B 6.41B Dec/2025
Tosoh JPY 759.27B 28.26B Dec/2025
Waters USD 1.99B 69.86M Dec/2025